Novasep Extends Custom Chiral Separation Capabilities

Novasep has added a current good manufacturing practices (cGMP) pilot-scale continuous chromatography system in its facility in Chasse sur Rhone, France. The company operates six FDA-inspected facilities that manufacture active pharmaceutical ingredients and advanced intermediates. Four of the facilities include chiral separation services ranging from preclinical to commercial supply. The company now operates 10 pilot- and commercial-scale HPLC systems and eight pilot- and commercial-scale continuous chromatography systems for producing batches as large as 1 metric ton with a total capacity of more than 150 metric tons per year.